Brief: Panacea Biotec Enters Into Agreement With Natco Pharma And Breckenridge Pharma
27/08/2018 11:00
Aug 27 (Reuters) - Panacea Biotec Ltd PNCA.NS :
* SAYS ENTERED INTO TRIPARTITE AGREEMENT WITH NATCO PHARMA
AND
BRECKENRIDGE PHARMACEUTICAL
* AGREEMENT FOR THE MANUFACTURE AND SUPPLY OF AZACITIDINE
INJECTION FOR THE U.S. MARKET
Source text: http://bit.ly/2BQ9Pgh
Further company coverage: PNCA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Panacea Biotec
See all newsBrief: Panacea Biotec Receives Letter Of Award For BOPV Supply Worth $8.205 Million
Brief: Panacea Biotec Unit Gets Show Cause Notice Alleging Total Tax Liability Of 40.6 Million Rupees
Brief: Panacea Biotec Files Appeal Against Fourth Industrial Tribunal (Mohali) Award
India's Panacea Biotec rises to record high on EU-backed dengue vaccine project
India Stocks: Indian shares rise as banks gain on RBI forex swap facility